Lotan Y - Search Results

1

Is a restaging TURBT necessary in high-risk NMIBC if the initial TURBT was performed with blue light?

Alsyouf M, Ladi-Seyedian SS, Konety B, Pohar K, Holzbeierlein JM, Kates M, Willard B, Taylor JM, Liao JC, Kaimakliotis HZ, Porten SP, Steinberg GD, Tyson MD, Lotan Y, Daneshmand S; Blue Light Cystoscopy with Cysview Registry Group. Alsyouf M, et al. Among authors: lotan y. Urol Oncol. 2023 Feb;41(2):109.e9-109.e14. doi: 10.1016/j.urolonc.2022.10.026. Epub 2022 Nov 24. Urol Oncol. 2023. PMID: 36435710

2

Economic impact of screening for bladder cancer using bladder tumor markers: a decision analysis.

Svatek RS, Sagalowsky AI, Lotan Y. Svatek RS, et al. Among authors: lotan y. Urol Oncol. 2006 Jul-Aug;24(4):338-43. doi: 10.1016/j.urolonc.2005.11.025. Urol Oncol. 2006. PMID: 16818188

3

Prostate cancer disease-free survival after radical retropubic prostatectomy in patients older than 70 years compared to younger cohorts.

Malaeb BS, Rashid HH, Lotan Y, Khoddami SM, Shariat SF, Sagalowsky AI, McConnell JD, Roehrborn CG, Koeneman KS. Malaeb BS, et al. Among authors: lotan y. Urol Oncol. 2007 Jul-Aug;25(4):291-7. doi: 10.1016/j.urolonc.2006.08.001. Urol Oncol. 2007. PMID: 17628294

4

Association of cyclin D1 and E1 expression with disease progression and biomarkers in patients with nonmuscle-invasive urothelial cell carcinoma of the bladder.

Shariat SF, Ashfaq R, Sagalowsky AI, Lotan Y. Shariat SF, et al. Among authors: lotan y. Urol Oncol. 2007 Nov-Dec;25(6):468-75. doi: 10.1016/j.urolonc.2006.09.011. Urol Oncol. 2007. PMID: 18047954

5

Urothelial bladder cancer: biomarkers for detection and screening.

Konety B, Lotan Y. Konety B, et al. Among authors: lotan y. BJU Int. 2008 Nov;102(9 Pt B):1234-41. doi: 10.1111/j.1464-410X.2008.07965.x. BJU Int. 2008. PMID: 19035887 No abstract available.

6

Role of fluorescence in situ hybridization in bladder cancer surveillance of patients with negative cytology.

Youssef RF, Schlomer BJ, Ho R, Sagalowsky AI, Ashfaq R, Lotan Y. Youssef RF, et al. Among authors: lotan y. Urol Oncol. 2012 May-Jun;30(3):273-7. doi: 10.1016/j.urolonc.2010.02.012. Epub 2010 May 6. Urol Oncol. 2012. PMID: 20451422

7

Urinary cytology for the detection of urothelial carcinoma of the bladder--a flawed adjunct to cystoscopy?

Bolenz C, West AM, Ortiz N, Kabbani W, Lotan Y. Bolenz C, et al. Among authors: lotan y. Urol Oncol. 2013 Apr;31(3):366-71. doi: 10.1016/j.urolonc.2011.01.017. Epub 2011 Mar 16. Urol Oncol. 2013. PMID: 21414815

8

Predictors of costs for robotic-assisted laparoscopic radical prostatectomy.

Bolenz C, Gupta A, Roehrborn CG, Lotan Y. Bolenz C, et al. Among authors: lotan y. Urol Oncol. 2011 May-Jun;29(3):325-9. doi: 10.1016/j.urolonc.2011.01.016. Urol Oncol. 2011. PMID: 21555102

9

Urothelial carcinoma at the uretero-enteric junction: multi-center evaluation of oncologic outcomes after radical nephroureterectomy.

Youssef RF, Shariat SF, Lotan Y, Cost N, Wood CG, Sagalowsky AI, Zigeuner R, Langner C, Chromecki TF, Montorsi F, Bolenz C, Margulis V. Youssef RF, et al. Among authors: lotan y. Urol Oncol. 2013 Jul;31(5):676-81. doi: 10.1016/j.urolonc.2011.05.006. Epub 2011 Jun 25. Urol Oncol. 2013. PMID: 21704538

10

Comprehensive handbook for developing a bladder cancer cystectomy database.

Lotan Y, Amiel G, Boorjian SA, Clark PE, Droller M, Gingrich JR, Guzzo TJ, Inman BA, Kamat AM, Karsh L, Nielsen ME, Smith ND, Shariat SF, Svatek RS, Taylor JM; Bladder Cancer Think Tank; Bladder Cancer Advocacy Network. Lotan Y, et al. Urol Oncol. 2013 Aug;31(6):812-26. doi: 10.1016/j.urolonc.2011.09.004. Epub 2011 Nov 6. Urol Oncol. 2013. PMID: 22056403

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

772 results

Search Page

Filters